Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,940 GBX | +0.41% | -4.64% | +8.11% |
May. 17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.11% | 5.45B | |
+37.34% | 723B | |
+32.22% | 598B | |
-2.19% | 364B | |
+20.40% | 331B | |
+3.25% | 288B | |
+16.42% | 244B | |
+9.78% | 210B | |
-5.36% | 208B | |
+8.66% | 169B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Transcript : Hikma Pharmaceuticals PLC, H1 2021 Earnings Call, Aug 06, 2021